Our facility houses validated vapour-phase liquid nitrogen cryostorage and integrated digital inventory systems. With established logistics partners, we support qualified cryo-transport to hospitals and clinical sites across Australia, Asia-Pacific, and globally. We also support direct-to-patient delivery models for time-sensitive autologous therapies.
From day-zero patient apheresis to final filled vials and bags, Cell Therapies safeguards cell viability with industry‑leading cryo & cold‑chain protocols.
